Clinical Trial: A Study About Fazirsiran in People With and Without Liver Problems
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hepatic Impairment
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics in Response to a Single Subcutaneous Dose of Fazirsiran (TAK-999) in Subjects With or Without
Brief Summary:
The main aim of this study is to learn how the body processes fazirsiran (pharmacokinetics [PK]) in people with mild, moderate, or severe liver problems, compared to people with normal liver function.The study will include participants with liver scarring (cirrhosis) and mild, moderate, or severe liver problems, and participants with normal liver function.All participants will be given 1 injection of fazirsiran and will be followed up for 6 months after the fazirsiran injection.
Read more